(Q38720238)

English

Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs

scientific article published on 20 January 2017

Statements

Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs (English)
Andres E Perez Bay
Jessica R Kirshner
Douglas MacDonald
Christopher Daly

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit